Poco F3 may launch as rebranded Redmi K40 in the global market - Times of India

Poco F3 may launch as rebranded Redmi K40 in the global market – Times of India


It was recently reported that one of the Redmi K40 series phones will be relaunched in global markets as a smartphone under the Poco brand. Now, a US FCC certification suggests that the Poco F3 will be a rebranded version of the Redmi K40 series phone.
The listing still does not make it clear whether Poco F3 will be a rebranded model of Redmi K40 or Redmi K40 smartphone.
A smartphone with model number M2012K11AG was spotted on a listing page of Infocomm Media Development Authority (IMDA) in February this year.
It was then alleged to be a Poco phone which was a rebranded version of the Redmi K40 series phone. The IMDA listing says that this revamped version of Redmi K40 will be a 5G phone.
The upcoming Poco F3 is said to be powered by Qualcomm Snapdragon 870 chipset similar to the Redmi K40. The handset is expected to come with 5G support and may be offered in 6GB, 8GB and 12GB RAM models.
Poco F3 is expected to feature a triple camera setup at the back. The camera system may comprise a 48MP main camera, 8MP ultra-wide sensor and a 5MP macro sensor.
For selfies, the device is said to feature a 20MP camera at the front. It is expected that the smartphone will house a 4520mAh battery with 33watt fast charging.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

Flipkart daily trivia quiz March 3, 2021: Get answers to these five questions to win gifts and Super coins - Times of India

Flipkart daily trivia quiz March 3, 2021: Get answers to these five questions to win gifts and Super coins – Times of India

Flipkart is back with another dose of its daily trivia quiz. As part of today’s quiz, participants stand a chance to win gifts, discount coupons and Flipkart Super Coins. In order to win these prizes, one has to answer all questions of the quiz correctly. Flipkart daily trivia quiz has five questions based on general […]

Pfizer, Oxford COVID-19 vaccines reduces severity of the disease in elderly: pre-print study – Health News , Firstpost

Symptomatic COVID-19 infections in those 70+ years of age also decreased, three weeks after a single shot of either vaccine was given. The Pfizer and Oxford-AstraZeneca vaccines for COVID-19 are highly effective in reducing severe coronavirus infection among people aged 70 years and above, according to a study. The research, posted as a pre-print and […]

%d bloggers like this: